FDG-PET/CT vs. Non-FDG Tracers in Less Explored Domains, An Issue of PET Clinics

Edited by Sandip Basu, DRM, DNB, MNAMS, Rakesh Kumar and Abass Alavi, MD
Publication Date
$78.99 $71.09
+ WishList
In this issue, guest editors bring their considerable expertise to this important topic.

Key Features
Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
ISBN 9780323897181
Product Format Book
Publication Date 2022
Author Information Edited by Sandip Basu, DRM, DNB, MNAMS, Professor, Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, Maharashtra, India; Rakesh Kumar, Director, CSIR-National Environmental Engineering Research Institute (CSIR-NEERI), Nehru Marg, Nagpur, Maharashtra, India and Abass Alavi, MD, Professor, Division of Nuclear Medicine, Department of Radiology, Hospital of the, University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
Table of Content Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions
An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms
18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies
Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2- [18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers
18F-FDG Versus Non-FDG PET Tracers in Multiple Myeloma
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
Fibroblast Activation Protein Inhibitor Theranostics
PET-CTBased Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous Disorders
Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings
Nonmalignant Thoracic Disorders: An Appraisal of Fluorodeoxyglucose and Non>fluorodeoxyglucose PET/Computed Tomography Applications
Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot: A Comparative Perspective with Other Functional Imaging Modalities
Utility of PET/Computed Tomography in Infection and Inflammation Imaging
Role of Fluorodeoxyglucose-PET in Interventional Radiology
Publication Date 21-06-2022
Pages 240
Stock Status In Stock
deltacomm1code Books
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account

Back to top